Patent details

EP3841877 Title: GENETICALLY MODIFIED MICE EXPRESSING HUMAN EPO

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3841877
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP20209073.4
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
18/05/2015
Grant date:
06/09/2023
EP Publication Date:
30/06/2021
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
23/11/2023
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
06/09/2023
EP B1 Publication Date:
06/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/05/2035
Lapsed By Expiration Date:
Patent Validated Date:
08/12/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
06/09/2023
 
 

 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, United States of America (US)

From:
06/09/2023
 
 

 

Name:
Yale University
Address:
Two Whitney Avenue, New Haven, CT 06510, United States of America (US)

From:
06/09/2023
 
 

 

Name:
Institute for Research in Biomedicine (IRB)
Address:
Via Francesco Chiesa 5, 6500 Bellinzona, Switzerland (CH)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
07/12/2023
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
MURPHY, Andrew J.
Address:
Tarrytown, CT 10591, United States of America (US)

2

Name:
STEVENS, Sean
Address:
Del Mar, CT 92014, United States of America (US)

3

Name:
FLAVELL, Richard
Address:
Guilford, CT 06437, United States of America (US)

4

Name:
MANZ, Markus
Address:
8091 Zürich, Switzerland (CH)

5

Name:
SHAN, Liang
Address:
St. Louis, MO 63105, United States of America (US)

Priority

Priority Patent Number:
201462000460 P
Priority Date:
19/05/2014
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A01K 67/027; C07K 14/535; C07K 14/715; C07K 14/54; C07K 14/52; C07K 14/505; C12N 9/00; A61K 49/00; G01N 33/50; C07K 14/47; C12N 9/14; C12Q 1/18;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
50/23
Publication date:
13/12/2023
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
36/23
Publication date:
06/09/2023
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202341
Publication date:
11/10/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202336
Publication date:
06/09/2023
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/05/2026
Annual Fee Number:
12
Annual Fee Amount:
600 Euro
Last Annual Payment Date:
23/04/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
500 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
07/12/2023 Outgoing Correspondence Letter no formal defects 2 PDF /2/3/5/9/1/0800919532/docs/ep20209073.4_1_580138l271.pdf
23/11/2023 Claims First filed claims 2 PDF /2/3/5/9/1/0800919532/docs/ep20209073.4_0_claims20231123094501571.pdf